What is Dunn Meadow?
Dunn Meadow operates as a specialized concierge pharmacy provider, fundamentally reimagining the patient experience through a high-touch service model. The organization addresses critical systemic failures in the healthcare sector, specifically targeting persistent challenges related to medication access and patient adherence. By integrating advanced technological platforms with a robust physical distribution network, Dunn Meadow delivers a streamlined, patient-centric approach that differentiates it from traditional retail pharmacy chains. The company's commitment to improving health outcomes through personalized care has established it as a key player in the evolving digital health ecosystem.
How much funding has Dunn Meadow raised?
Dunn Meadow has raised a total of $466K across 2 funding rounds:
Debt
$150K
Debt
$316K
Debt (2020): $150K with participation from PPP
Debt (2021): $316K led by PPP
Key Investors in Dunn Meadow
PPP
Public-Private Partnership
What's next for Dunn Meadow?
With the recent influx of capital, Dunn Meadow is well-positioned to accelerate its growth trajectory and expand its service footprint. The strategic focus will likely shift toward scaling its proprietary infrastructure to meet increasing demand for concierge-level pharmaceutical care. As the company matures, the emphasis will remain on optimizing patient adherence metrics and leveraging data-driven insights to refine its service delivery model. This late-stage financing provides the necessary runway to enhance operational efficiencies and potentially explore new market segments, ensuring that Dunn Meadow remains at the forefront of the pharmacy innovation sector.
See full Dunn Meadow company page
